MarketCap
Geron Corporation GERN
€ 0.89
4.21%
Facebook
X
Telegram
Geron Corporation Kurzfristige Verbindlichkeiten | GERN
Kurzfristige Verbindlichkeiten Jährlich Geron Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112 M | 88.3 M | 108 M | 76.7 M | 45.5 M | 30.9 M | 28.2 M | 7.55 M | 6.52 M | 7.87 M | 6.63 M | 41.8 M | 7.59 M | 14.1 M | 13.4 M | 40.8 M | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 112 M | 6.52 M | 39.7 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
42.3 M | - | -1.58 % | $ 28.1 M |  China |
 |
Seer
SEER
|
15.7 M | $ 1.63 | 0.18 % | $ 90.4 M |  USA |
 |
Gracell Biotechnologies
GRCL
|
221 M | - | - | $ 3.37 B | China |
 |
Stoke Therapeutics
STOK
|
57.9 M | $ 26.51 | 1.69 % | $ 1.57 B | USA |
 |
Sutro Biopharma
STRO
|
75.1 M | $ 9.57 | 4.08 % | $ 81.3 M | USA |
 |
Taysha Gene Therapies
TSHA
|
26.6 M | $ 4.34 | 6.11 % | $ 1.39 B | USA |
 |
Soligenix
SNGX
|
3.7 M | $ 0.34 | 0.54 % | $ 1.76 M | USA |
 |
Spruce Biosciences
SPRB
|
10.1 M | $ 46.46 | 8.78 % | $ 35.6 M | USA |
 |
Supernus Pharmaceuticals
SUPN
|
338 M | $ 26.14 | -2.24 % | $ 1.48 B | USA |
 |
Savara
SVRA
|
20.4 M | $ 4.82 | 9.93 % | $ 1.07 B | USA |
 |
Viking Therapeutics
VKTX
|
76.7 M | $ 26.86 | 4.15 % | $ 3.03 B | USA |
 |
Teligent, Inc.
TLGT
|
23.1 M | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
46 M | - | - | $ 2.91 B | USA |
 |
TG Therapeutics
TGTX
|
154 M | $ 59.78 | 3.1 % | $ 8.63 B | USA |
 |
Aphria Inc.
APHA
|
170 M | - | -0.45 % | $ 4.87 B |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
1.87 M | - | -0.90 % | $ 104 M | USA |
 |
Chiasma, Inc.
CHMA
|
16.7 M | - | -6.00 % | $ 238 M | USA |
 |
Wave Life Sciences Ltd.
WVE
|
95.1 M | $ 3.37 | 4.66 % | $ 568 M |  Singapore |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
34.9 M | - | - | $ 376 M | USA |
 |
AzurRx BioPharma, Inc.
AZRX
|
15.5 K | - | 2.07 % | $ 34.4 M | USA |
 |
Cerecor Inc.
CERC
|
15.2 M | - | -1.68 % | $ 283 M | USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
30.5 M | - | - | $ 1.63 B | USA |
 |
Auris Medical Holding Ltd.
EARS
|
3.03 M | - | -1.77 % | $ 39.2 M |  Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
178 M | - | 0.34 % | $ 2.98 B | USA |
 |
GW Pharmaceuticals plc
GWPH
|
160 M | - | - | $ 6.81 B |  Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
29.5 M | - | - | $ 1.7 B | USA |
 |
XBiotech
XBIT
|
7.93 M | $ 1.88 | 0.53 % | $ 57.3 M | USA |
 |
Neos Therapeutics, Inc.
NEOS
|
63.4 M | - | -2.54 % | $ 57.2 M | USA |
 |
Xencor
XNCR
|
95.9 M | $ 36.19 | 6.28 % | $ 2.69 B | USA |
 |
Odonate Therapeutics, Inc.
ODT
|
27.1 M | - | -3.18 % | $ 58.5 M | USA |
 |
Orphazyme A/S
ORPH
|
167 M | - | -2.25 % | $ 31.3 M |  Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
55.8 M | - | -10.74 % | $ 89.9 M | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
8.86 K | - | - | $ 1.77 B | USA |
 |
Xenetic Biosciences
XBIO
|
968 K | $ 1.87 | 0.31 % | $ 3.18 M | USA |
 |
Translate Bio, Inc.
TBIO
|
101 M | - | - | $ 2.81 B | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
21.4 M | - | - | $ 1.94 B | Canada |
 |
Exicure
XCUR
|
3.89 M | $ 0.91 | 2.77 % | $ 5.73 M | USA |
 |
Urovant Sciences Ltd.
UROV
|
30.9 M | - | - | $ 532 M | Britain |
 |
Acceleron Pharma Inc.
XLRN
|
60.2 M | - | - | $ 10.9 B | USA |